|View printer-friendly version|
|CytomX Therapeutics to Present at 12th Annual BIO Investor Forum|
SOUTH SAN FRANCISCO – October 1, 2013 – CytomX Therapeutics, the Probody™ therapeutics company, today announced that the Company’s Chief Executive Officer, Sean McCarthy, D. Phil., will present at the 12th Annual BIO Investor Forum on Tuesday, Oct. 8, 2013, at 9 a.m. PDT. Dr. McCarthy will provide a company overview and discuss recent progress with CytomX’s Probody Platform and therapeutic programs.
Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual BIO Investor Forum features leading private and emerging public companies. The meeting will take place Oct. 8-9, 2013, at the Palace Hotel in San Francisco.